Dr. Lundeberg has, in recent years, focused on developing methodologies in spatial multiomics. The pioneering work on mRNA was published in Science 2016 and was the first method to spatially barcode mRNA from tissue sections. The developed technology, Spatial Transcriptomics (ST), was later commercialized by 10x Genomics and is today available worldwide as Visium, and is, by far, the most used spatial transcriptomics platform. The technology was also featured in Nature Methods as the Method of the Year 2020 as one of the Top 10 Innovations 2021 by the journal The Scientist. The journal Nature also highlighted it as one of the Seven Technologies to Watch in 2022. Dr. Lundeberg has publications demonstrating technology development (super-resolution ST by deep data fusion or expansion microscopy, spatial VDJ of B and T cells, multimodal spatial mass spectrometry, 3D spatial reconstruction by deep learning) and examples of spatial analysis’s impact on biology. The current research focuses on expanding the spatial modalities and developing new AI tools and applications in the human cell atlas (human developmental cell atlas and the current follow-up project Atlas of Childhood Diseases), neurology (ALS, Alzheimer’s and Parkinson’s disease), and cancer (prostate and breast cancer).
ACS CONFERENCE 2026 